Editor: Aamir Ahmad, PhD, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA
Deadline: 31 August 2017
Cancer is a deadly disease that affects millions of lives worldwide. The fight against cancer relies heavily on the availability of robust biomarkers for diagnosis, therapy and prognosis. In recent years, non-coding RNAs have attracted a lot of attention for their role in human cancers. The expression levels of many of these non-coding RNAs have been found to be altered with the progression of disease and there is evidence to suggest their role in regulation of gene expression. microRNAs (miRNAs) are perhaps the most studied non-coding RNAs but newer studies have revealed some interesting information on the role of other non-coding RNAs in cancer as well. These include long non-coding RNAs, snoRNAs, siRNAs, snRNAs, piRNAs, exRNAs etc.
This special issue on the ‘non-coding RNAs in Cancer’ welcomes research as well as review articles that showcase the emerging importance of non-coding RNAs in cancer diagnosis and therapy. Since there already is so much information on miRNAs in cancer, preference will be given to articles that focus on other non-coding RNAs. Interested authors are encouraged to contact the journal at firstname.lastname@example.org for general queries or if they wish to check with the guest editor regarding the suitability of their article for this special issue. Articles submitted to this special issue will be published, with waived publication costs, provided the submissions are made by the due date.
Submit your papers via the online submission site.
Keywords: Cancer; non-coding RNA; diagnosis; therapy; long non-coding RNA; snoRNA; snRNA; piRNA; exRNA